PTPRC and B-cell chronic lymphocytic leukemia: Use of pSyk inhibitor R406 confirmed that active Syk kinase plays an important role in Th-mediated CLL proliferation by decreasing CD45 activityhi populations, potentially via CD43 regulation (Figures S7–S9).